Shin Nippon Biomedical Laboratories Ltd. | Key People and Executives
Ryoichi Nagata
Chairman, President & Chief Executive Officer
Ken Takanashi
COO, Representative Director & Vice President
Shinji Nitanda
Chief Financial Officer & Managing Director
Hideyuki Hirama
Managing Director & Chief Strategy Officer
Kazumi Uchi
Director, Head-Finance & Accounting
Satoshi Matsumoto
MD, Head-General Affairs & Personnel
Koichiro Fukuzaki
Vice Chairman
Shinichi Fukumoto
Independent Outside Director
Takashi Yamashita
Independent Outside Director
Ryoichi Nagata
Chairman, President & Chief Executive Officer
Ken Takanashi
COO, Representative Director & Vice President
Shinji Nitanda
Chief Financial Officer & Managing Director
Jun Ozaki
Executive Officer
Hideyuki Hirama
Managing Director & Chief Strategy Officer
Kazumi Uchi
Director, Head-Finance & Accounting
Hidenobu Samejima
Senior Managing Executive Officer
Shuichi Kanazashi
Managing Executive Officer
Shunji Haruta
Executive Officer & Manager-Translational Research
Masahiro Uto
Executive Officer
Satoshi Matsumoto
MD, Head-General Affairs & Personnel
Koichiro Fukuzaki
Vice Chairman
Hideshi Tsusaki
Managing Executive Officer & Senior Head-Sales
Tomoaki Honda
Executive Officer & Senior Manager-Internal Audit
Toshihiko Makino
Executive Officer
Chise Kanda
Investor Relations Contact
Shinichi Fukumoto
Independent Outside Director
Takashi Yamashita
Independent Outside Director
Address |
St. Luke's Tower, 12/F Tokyo Tokyo 104 Japan
|
Employees
|
- |
Website |
http://www.snbl.co.jp |
Updated |
07/08/2019 |
Shin Nippon Biomedical Laboratories, Ltd. is a contract research organization providing drug development services including safety research, clinical pharmacology, and clinical trials. Its operations are carried out through the following segments: Preclinical Business, Clinical Business, Translational Research Business, Medipolis Business, and Others. The Preclinical Business segment verifies the efficacy and safety of new drugs using experimental animals and bacterial cells. |